Mabcampath TM
Listen to the Pronunciation:
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: alemtuzumab
Pack: Mabcampath 30 mg/mL injection, 3 x 1 mL vials
Brand name
(ARTG)
: MABCAMPATH alemtuzumab 30mg/mL concentrate solution for infusion vialConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
Listen to the audio transcription of the CMI leaflet.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
The treatment of patients with B-cell chronic lymphocytic leukaemia (CLL) who have relapsed after failure of two prior therapies.,MabCampath is indicated for the treatment of patients with B-cell chronic lymphocytic leukaemia (B-CLL).
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, intravenous infusion
- Intravenous
- clear, colourless to slightly yellow concentrate
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Refrigerate
- Shelf lifetime is 4 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 3 x 1 mL vials pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient alemtuzumab
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
